Contract Service Directory

Coating Place, Inc.





Company Headquarters

200 Paoli Street
Verona, WI 53593
United States

Company Description

Coating Place, Inc. has developed and manufactured modified release oral dosage products since 1976. We are the leading provider of Wurster fluid bed microencapsulation. Our services include formulation development, technology transfer, scale-up and commercial manufacturing in a GMP environment. Our facility processes solvent and aqueous formulations. Other services offered are capsule filling, tablet compression, pan coating, extrusion spheronisation and roller compaction. We are registered with the FDA and licensed by the DEA.

Contract Service Directory

    Content From Coating Place, Inc.

    Related Content

    • Breaking News | CRO News | Promotions & Moves
      Parexel Adds Experts to Regulatory Consulting Group

      Parexel Adds Experts to Regulatory Consulting Group

      Four new hires from U.S. FDA and MHRA will serve as technical vice presidents
      12.10.19

    • Breaking News | Drug Development | Trials & Filings
      SK Bio Gains FDA Approval for XCOPRI

      SK Bio Gains FDA Approval for XCOPRI

      Marks the first time a Korean company has independently brought a compound from discovery to U.S. FDA approval
      11.25.19

    • Biologics, Proteins, Vaccines | Biosimilars
      Biopharma Over 20 Years

      Biopharma Over 20 Years

      A look at the key trends that have impacted the biopharma industry over the years.
      K. John Morrow, Jr. and Eric S. Langer, BioPlan Associates 11.20.19


    • CPL

      CPL's David Tyler

      CPL's director of business development was on hand at Contract Pharma 2019.
      Contract Pharma


    • Contract Pharma’s 18th Conference & Tabletop Exhibit Was a Another Success!

      Contract Pharma’s 18th Conference & Tabletop Exhibit Was a Another Success!

      Contracting & Outsourcing 2019 featured a sold-out exhibit hall and lively conference sessions.
      10.22.19


    • Breaking News
      Contract Pharma’s 18th Conference & Tabletop Exhibit Was a Another Success!

      Contract Pharma’s 18th Conference & Tabletop Exhibit Was a Another Success!

      Contracting & Outsourcing 2019 featured a sold-out exhibit hall and lively conference sessions.
      10.18.19

    • VIDEO: Contract Pharma 2019 Video Highlights!

      VIDEO: Contract Pharma 2019 Video Highlights!

      Contracting & Outsourcing 2019 featured a sold-out exhibit hall and lively conference sessions.
      10.02.19



    • Regulatory Affairs
      Quality Metrics Feedback

      Quality Metrics Feedback

      A look at FDA’s Quality Metrics Initiative, a complicated issue for all of pharma stakeholders
      Gil Roth, President, Pharma & Biopharma Outsourcing Association 09.16.19

    • Breaking News | Clinical Trials | Industry News | Inspections | QA/QC
      FDA Extends CRADA with CluePoints

      FDA Extends CRADA with CluePoints

      Aims to further explore a data-driven approach to quality oversight in clinical trials
      09.11.19

    • Breaking News | cGMP Manufacture | Clinical Trial Materials | Drug Development | Industry News
      Catalent Invests $9M in New Clinical Supply Facility

      Catalent Invests $9M in New Clinical Supply Facility

      New 24,257 sq.-ft. facility in San Diego will specialize in services for early-phase clinical trials
      09.05.19


    • Industry News | Logistics | Supply Chain
      Marken Expands Services for Home-based Clinical Trials

      Marken Expands Services for Home-based Clinical Trials

      Direct to patient logistics include clinical drug storage, direct-to-patient delivery, biologic sample collection, central pharmacy and nursing services
      08.20.19

    • cGMP Manufacture | Collaborations & Alliances
      NIIMBL, FDA to Advance Innovation in Bio Manufacturing

      NIIMBL, FDA to Advance Innovation in Bio Manufacturing

      CRADA enables FDA and NIIMBL to support investments in regulatory science research, and training needed to foster advanced manufacturing innovations
      08.01.19

    • Trials & Filings
      FDA Accepts RedHill Biopharma’s NDA for Talicia

      FDA Accepts RedHill Biopharma’s NDA for Talicia

      Commercial launch of H. pylori treatment is planned shortly following potential FDA approval
      07.16.19

    • Extractables and Leachables | Laboratory Testing
      The FDA Gets Stricter with E&L Oversight, Can the Industry Keep Up?

      The FDA Gets Stricter with E&L Oversight, Can the Industry Keep Up?

      Andrew Kolbert of Avomeen discusses FDA oversight of E&L testing, complications that arise, and the expertise needed to keep up with changing quality standards
      Kristin Brooks, Contract Pharma 07.11.19

    • Trials & Filings
      Sierra’s Momelotinib Granted FDA Fast Track Designation

      Sierra’s Momelotinib Granted FDA Fast Track Designation

      Underscores potential for momelotinib to address unmet needs of patients with Intermediate/High-Risk myelofibrosis who have previously received a JAK inhibitor
      06.19.19